The 2020 Progenitor Cell Translation Consortium (PCTC) Cardiovascular Bioengineering (CVBE) Symposium co-hosted by the UAB Department of Biomedical Engineering, will feature a keynote address by Victor Dzau, M.D., president of the National Academy of Medicine. Dzau, a professor of Medicine at Duke University will speak on “The Future of Heart Failure Therapy/Paracrine Mechanism of Stem Cell Therapy,” on December 5, 2020 at 9:10 a.m.
Source: medicine.duke.eduDue to the worldwide outbreak of coronavirus (COVID-19), the symposium will be held in a virtual format via Zoom for the first time. The event was originally scheduled for the spring in Göttingen, Germany, and was anticipated to draw speakers and guests from around the globe. This collaborative conference, focusing on cardiac gene and cell therapy topics, is co-hosted and co-organized by UAB BME Chair Jay Zhang, M.D., Ph.D., and Wolfram Zimmerman, Ph.D., of the University Medical Center Göttingen. Topics addressed will include areas of gene editing, induced pluripotent stem cells, cardiac stem cells in the context of heart failure, cardiovascular bioengineering, vascular tissue engineering, cardiac development, exosomes, microRNAs, and mitochondria.
In addition to his role of president of the National Academy of Medicine (NAM) (formerly the Institute of Medicine), Dzau also serves as the vice chair of the National Research Council and is chancellor emeritus and James B. Duke Professor of Medicine at Duke University Health System. Prior to these roles, he was the Hersey Professor of Theory and Practice of Medicine and Chairman of Medicine at Harvard Medical School’s Brigham and Women’s Hospital, and Chairman of the Department of Medicine and Director of the Falk Cardiovascular Research Center at Stanford University. Dzau is a prominent world health leader and advises governments, corporations, and universities worldwide. He has also made a major impact on health and medicine through his seminal research in cardiovascular medicine and genetics and his leadership in health innovation.
Registration is free, but will be required for access to the symposium. Register online at: https://translationalcells.org/content/pctc-cardiovascular-bioengineering-cvbe-symposium